Evaluation of free and peptide bound collagen crosslink excretion in different skeletal diseases

Annals of the Rheumatic Diseases

Volumn 62, Issue 1, 2003, Pages 65-67

  Muller A ^a,c   Jakob, K ^b   Hein, G E ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HELIOS KLINIKUM ERFURT   (Germany)

^c Rheumalabor ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COLLAGEN; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; PEPTIDE; PYRIDINIUM DERIVATIVE; PYRIDINOLINE;

ADULT; ARTHRITIS; ARTICLE; BONE DISEASE; CHILD; CONTROLLED STUDY; CROSS LINKING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; URINALYSIS; URINARY EXCRETION;

ADULT; AGED; AMINO ACIDS; ARTHRITIS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; STATISTICS, NONPARAMETRIC;

EID: 0037216568     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.1.65     Document Type: Article

References (14)

1. Robins SP. Cross-linking of collagen. Isolation, structural characterization and glycosylation of pyridinoline. Biochem J 1983;215:167-73.
2. Ogawa T, Ono T, Tsuda M, Kawanishi Y. A novel fluor in insoluble collagen: A crosslinking moiety in collagen molecule. Biochem Biophys Res Commun 1982;107:1252-7.
3. Eyre DR. The specificity of collagen cross-links as markers of bone and connective tissue degradation. Acta Orthop Scand Suppl 1995;266:166-70.
4. Knott L, Bailey AJ. Collagen cross-links in mineralizing tissues: A review of their chemistry, function, and clinical relevance. Bone 1998;22:181-7.
5. Bennett RM. Psoriatic arthritis. In: McCarthy DE, ed. Arthritis and Allied Conditions. New York: Lea and Febiger, 1979:645.
6. Müller A, Hein G, Franke S, Herrmann D, Henzgen S, Roth A, et al. Quantitative analysis of pyridinium crosslinks of collagen in the synovial fluid of patients with rheumatoid arthritis using high-performance liquid chromatography. Rheumatol Int 1996;16:23-8.
7. Hein G, Franke S, Müller A, Braunig E, Eidner T, Stein G. The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis. Clin Rheumatol 1997;16:167-72.
8. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 1995;10:641-9.
9. Randall AG, Kent GN, Garcia-Webb P, Bhagat CI, Pearce DJ, Gutteridge DH, et al. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links. J Bone Miner Res 1996;11:1176-84.
10. Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JL, et al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 1996;81:3366-71.
11. Colwell A, Eastell R. The renal clearance of free and conjugated pyridinium cross-links of collagen. J Bone Miner Res 1996;11:1976-80.
12. Takahashi M, Suzuki M, Naitou K, Miyamoto S, Kushida K. Comparison of free and peptide-bound pyridinoline cross-links excretion in rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford) 1999;38:133-8.
13. Abbiati G, Bartucci F, Longoni A, Fincato G, Galimberti S, Rigoldi M, et al. Monitoring of free and total urinary pyridinoline and deoxypyridinoline in healthy volunteers: Sample relationships between 24-h and fasting early morning urine concentrations. Bone Miner 1993;21:9-19.
14. Hein G, Schmidt F, Müller A. Investigations of bone resorption activity in psoriatic arthritis in relation to psoriasis and rheumatoid arthritis. Eur J Med Res 1999;4:193-8.